Results 101 to 110 of about 1,291 (167)
Mitochondrial Dysfunction Driven by MARylation of GLUD1 as a Key Barrier to Sorafenib‐Induced Ferroptosis in Hepatocellular Carcinoma
Advanced Science, EarlyView.Sorafenib limits its ferroptotic efficacy in hepatocellular carcinoma by triggering a self‐limiting metabolic bottleneck. It drives SIRT4‐mediated mono‐ADP‐ribosylation of GLUD1 at R60, initiating mitophagy‐coupled, non‐canonical ubiquitination via the DTX3L DTC domain.Kangnan Zhang, Wenhui Mo, Jinlu Han, Shihao Xiang, Qinghui Zhang, Bin Liu, Qin Yu, Lingxi Chen, Hao Chang, Ling Xu +9 morewiley +1 more sourceMultiomics identifies the link between intratumor steatosis and the exhausted tumor immune microenvironment in hepatocellular carcinoma
Hepatology, EarlyView., 2022 Steatotic HCC can be diagnosed by MRI and forms a pro‐tumor immune microenvironment with high expression of PD‐L1, M2 polarization of macrophages and activation of CAFs, which may be a good target for combined immunotherapy. Abstract Background and Aims
Immunotherapy has become the standard‐of‐care treatment for hepatocellular carcinoma (HCC), but its ...Hiroki Murai, Takahiro Kodama, Kazuki Maesaka, Shoichiro Tange, Daisuke Motooka, Yutaka Suzuki, Yasuyuki Shigematsu, Kentaro Inamura, Yoshihiro Mise, Akio Saiura, Yoshihiro Ono, Yu Takahashi, Yota Kawasaki, Satoshi Iino, Shogo Kobayashi, Masashi Idogawa, Takashi Tokino, Tomomi Hashidate‐Yoshida, Hideo Shindou, Masanori Miyazaki, Yasuharu Imai, Satoshi Tanaka, Eiji Mita, Kazuyoshi Ohkawa, Hayato Hikita, Ryotaro Sakamori, Tomohide Tatsumi, Hidetoshi Eguchi, Eiichi Morii, Tetsuo Takehara +29 morewiley +1 more sourceProteogenomic characterization of cholangiocarcinoma
Hepatology, EarlyView., 2022 Proteogenomic characterization of cholangiocarcinoma with therapeutic strategies Abstract Background and Aims
Cholangiocarcinoma (CCA) is a highly heterogeneous cancer with limited understanding and few effective therapeutic approaches. We aimed at providing a proteogenomic CCA characterization to inform biological processes and treatment ...Mengjie Deng, Peng Ran, Lingli Chen, Yunzhi Wang, Zixiang Yu, Ke Cai, Jinwen Feng, Zhaoyu Qin, Yanan Yin, Subei Tan, Yang Liu, Chen Xu, Guoming Shi, Yuan Ji, Jian‐Yuan Zhao, Jian Zhou, Jia Fan, Yingyong Hou, Chen Ding +18 morewiley +1 more sourceDevelopment‐Informed Microsphere Assemblies Enable Spatiotemporally Programmed Bone–Vascular Organoid‐Like Constructs for Large Bone Defect Repair
Advanced Science, EarlyView.Single‐cell‐guided prioritization of BMP4 and VEGFA is combined with temporally programmed BMSCs and a Matrigel‐free GelMA/PEO/bioactive‐glass assembled‐microsphere matrix to generate bone–vascular organoid‐like constructs. The platform coordinates osteogenic differentiation, endothelial activation, vascular‐like microchannel formation, and ...Renhao Ni, Xinyi Shi, Tong Zhu, Guanrong Li, Lei Chang, Shengtao Li, Jingyi Chi, Chen Shi, Zeming Hu, Rong Xu, Yingchun Zhu, Yang Luo, Yichen Chen, Fan Yang, Yabin Zhu +14 morewiley +1 more sourceAdeno‐associated virus serotype 2 capsid variants for improved liver‐directed gene therapy
Hepatology, EarlyView., 2022 Abstract Background and Aims
Current liver‐directed gene therapies look for adeno‐associated virus (AAV) vectors with improved efficacy. With this background, capsid engineering is explored. Whereas shuffled capsid library screenings have resulted in potent liver targeting variants with one first vector in human clinical trials, modifying natural ...Nadja Meumann, Marti Cabanes‐Creus, Moritz Ertelt, Renina Gale Navarro, Julie Lucifora, Qinggong Yuan, Karin Nien‐Huber, Ahmed Abdelrahman, Xuan‐Khang Vu, Liang Zhang, Ann‐Christin Franke, Christian Schmithals, Albrecht Piiper, Annabelle Vogt, Maria Gonzalez‐Carmona, Jochen T. Frueh, Evelyn Ullrich, Philip Meuleman, Steven R. Talbot, Margarete Odenthal, Michael Ott, Erhard Seifried, Clara T. Schoeder, Joachim Schwäble, Leszek Lisowski, Hildegard Büning +25 morewiley +1 more sourceHypofractionated Radiotherapy Elicits Tumor‐Derived APOC2 to Drive Inflammatory Monocyte Differentiation and Potentiate Anti‐Tumor Immunity in Colorectal Cancer
Advanced Science, EarlyView.Hypofractionated radiotherapy relieves ATF3‐mediated repression of tumor‐derived APOC2 in preclinical models, linking lipid remodeling to IFN‐I‐responsive Ly6A+ monocytes and CD8+ T‐cell responses. In patients receiving combined neoadjuvant therapy, rising serum APOC2 associates with pathological complete response.Qian Xu, Haihong Wang, Mingjie Li, Zhenwei Zou, Lichao Liu, Linlin Zheng, Donglin Kang, Ruijie Sun, Cheng Cheng, Ke Xu, Jinghua Ren, Lan Zhang, Chaoqun Han, Peng Zhang, Kaixiong Tao, Zhenyu Lin, Tao Zhang +16 morewiley +1 more sourceAIF1+CSF1R+ MSCs, induced by TNF‐α, act to generate an inflammatory microenvironment and promote hepatocarcinogenesis
Hepatology, EarlyView., 2022 Mesenchymal stem cells subset, educated by TNF‐α, are involved to generate inflammatory microenvironment and promote hepatocarcinogenesis Abstract Background and Aims
Increasing evidence suggests that mesenchymal stem cells (MSCs) home to injured local tissues and the tumor microenvironment in the liver.Chen Zong, Yan Meng, Fei Ye, Xue Yang, Rong Li, Jinghua Jiang, Qiudong Zhao, Lu Gao, Zhipeng Han, Lixin Wei +9 morewiley +1 more sourceHistone Chaperone ASF1B Promotes Progenitor‐Like Cell States in Hepatocellular Carcinoma Through H3.3‐Dependent SOX9 Transcriptional Activation
Advanced Science, EarlyView.ASF1B is reactivated as an oncofetal histone chaperone in hepatocellular carcinoma and promotes progenitor‐like malignant cell states. Mechanistically, ASF1B cooperates with H3.3/HIRA‐dependent chromatin regulation to activate SOX9 transcription. ASF1B and H3.3 also exhibit dynamic co‐condensation behavior, suggesting an additional biophysical feature ...Xiaona Fang, Beilei Liu, Shan Liu, Liuxian Ban, Yuan Cheng, Jiao Huang, Jie Luo, Yu Zhang, Lanqi Gong, Yuma Yang, Jinlin Huang, Baifeng Zhang, Yizhuo Zhang, Qian Yan, Xin‐Yuan Guan +14 morewiley +1 more sourceA nationwide assessment of hepatocellular adenoma resection: Indications and pathological discordance
Hepatology Communications, EarlyView., 2022 Abstract
Hepatocellular adenomas (HCAs) are benign liver tumors associated with bleeding or malignant transformation. Data on the indication for surgery are scarce. We analyzed indications and outcome of patients operated for HCAs < 50 mm compared to HCAs ≥ 50 mm. Changes in final postoperative diagnosis were assessed.Martijn P. D. Haring, Arthur K. E. Elfrink, Christiaan A. J. Oudmaijer, Paul C. M. Andel, Alicia Furumaya, Nenke de Jong, Colin J. J. M. Willems, Thijs Huits, Julie M. L. Sijmons, Eric J. T. Belt, Koop Bosscha, Esther C. J. Consten, Mariëlle M. E. Coolsen, Peter van Duijvendijk, Joris I. Erdmann, Paul Gobardhan, Robbert J. de Haas, Tjarda van Heek, Hwai‐Ding Lam, Wouter K. G. Leclercq, Mike S. L. Liem, Hendrik A. Marsman, Gijs A. Patijn, Türkan Terkivatan, Babs M. Zonderhuis, Izaak Quintus Molenaar, Wouter W. te Riele, Jeroen Hagendoorn, Alexander F. M. Schaapherder, Jan N. M. IJzermans, Carlijn I. Buis, Joost M. Klaase, Koert P. de Jong, Vincent E. de Meijer, the Dutch Benign Liver Tumor Group, R. B. Takkenberg, J. Verheij, O. M. van Delden, J. I. Erdmann, B. V. van Rosmalen, A. Furumaya, G. Kazemier, D. Ramsoekh, J. N. M. IJzermans, R. A. de Man, M. D. Doukas, M. G. Thomeer, A. J. Klompenhouwer, A. F. M. Schaapherder, M. E. Tushuizen, M. J. Coenraad, A. S. L. P. Crobach, M. C. Burgmans, S. Feshtali, M. M. E. Coolsen, M. Kramer, J. C. Beckervordersandforth, I. V. Samarska, C. van der Leij, R. Miclea, J. H. W. de Wilt, P. B. van den Boezem, E. T. T. L. Tjwa, I. Munsterman, S. Vos, S. van Koeverden, V. E. de Meijer, F. J. C. Cuperus, R. J. de Haas, E. W. Duiker, M. P. D. Haring +70 morewiley +1 more source